9 
for an oversight body; Representative Cbre's hearing on June 22 provides a 
model for the type of oversight Congress can exert. Other committees already 
in place such as RAC and IRBs provide oversight. 
Dr. Miller said he was not convinced of the value of an oversight group but 
suggested political realities require that seme body be in place to provide 
oversight. Dr. Harvin replied that just because something is inevitable does 
not mean one should support it. 
Dr. McCarthy felt that currently there are not enough issues to occupy such an 
oversight body. However, as issues arise, some oversight body should be in 
place to evaluate them. The HHS Ethics Committee might fill this function. 
To permit a vote on the Gottesman language, Cr. Nightingale withdrew her motion, 
and Dr. Martin withdrew his second. 
Dr. Saginor called for a vote on Dr. Gottesman's preposed language. By a vote 
of seven in favor and none opposed , the motion carried. It was the unanimous 
recommendation of the Working Group that the proposal be published in the 
Federal Register for comment. 
Dr. Nightingale then moved the following: 
"The working group recommends to RAC that RAC support the 
creation of a national committee to review and discuss the 
human applications of genetic and other biomedical 
technologies." 
Dr. Gottesman seconded the motion. 
Dr. Walters pointed out that the language of Dr. Nightingale's motion was 
broader than the language specifying the commission proposed by Representative 
Gore. By a vote of four in favor and three opposed , the working group recom- 
mended Dr. Nightingale's motion. Mr. Mitchell, however, cast his vote to 
make a tie. 
Dr. Harvin moved the meeting be adjourned. Mr. Mitchell adjourned the meeting 
at 3:20 p.m., June 24, 1983. 
U70] 
